pharmaceutical industryScienceHighlights from the Burrill Personalized Medicine MeetingScienceHow Several Drugs can Crush the Defenses of TuberculosisScienceCourt Rejects Vioxx LawsuitScienceSmaller Not Always Better: Microcapsules beat Nanoparticles for Making Drugs with Less WasteScienceGenerics Keep Drug Inflation in Single DigitsScienceIndian Court Denies Novartis Challenge to Anti-'Evergreening' RuleScienceFDA Panel Says Glaxo Diabetes Drug Avandia Should Stay on MarketScienceGlaxo Gets Smacked by FDA Scientist: $1.4 Billion Diabetes Drug Should Be Pullled From MarketScienceAvandia, Whale Feces and the Culture of ScienceScienceBillions of Dollars Later, New Diabetes Drugs No Better Than Old OnesSciencePay-For-Performance Pharmaceuticals: Satisfaction Guaranteed or Your Money BackScienceHolsinger Admits More Allegiance to the President Than the People; Rebounds With Support of National Health Care and Controlling Drug AdvertisingScienceFaulty Use of Animal Models Delays Drug DevelopmentScienceReports of Avandia-Related Heart Attacks Jump, Highlight Flawed FDA MonitoringScienceGoogle Employee Sets Off 'Sicko' Advertisement ControversyScienceA New Source for Drugs: Combinations of Old DrugsScienceSenators Push for Pharmaceutical Industry Gift RegistrySciencePatients, Pharmaceutical Companies Take Britain to Court Over Alzheimer Drug AccessScienceIrony Lost on Scientists Working to Create Drugs in MushroomsScienceOily Discharge Doesn't Discourage Diet Drug BuyersScienceFDA Advisers Say Weight Loss Drug Causes Depression, AnxietyScienceThe Yin and Yang of the FDAScienceAvandia Skeptic Alleges Intimidation by Company, FDA Issues Strict WarningsScienceGlaxo, Doctors Battle Over Interpretation of New Avandia StudyMore Stories